The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>

Solomon, Diane

doi:10.1001/jama.287.16.2114

Cited by 3,104Cervical Cancer and HPV ResearchClinical practice guidelines implementationWomen's cancer prevention and management

The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>

Solomon, Diane·2002·JAMA

DOI 10.1001/jama.287.16.2114

Open this paper in CoChat — free account

Abstract

Objectives The Bethesda 2001 Workshop was convened to evaluate and update the 1991 Bethesda System terminology for reporting the results of cervical cytology. A primary objective was to develop a new approach to broaden participation in the consensus process. Participants Forum groups composed of 6 to 10 individuals were responsible for developing recommendations for discussion at the workshop. Each forum group included at least 1 cytopathologist, cytotechnologist, clinician, and international representative to ensure a broad range of views and interests. More than 400 cytopathologists, cytotechnologists, histopathologists, family practitioners, gynecologists, public health physicians, epidemiologists, patient advocates, and attorneys participated in the workshop, which was convened by the National Cancer Institute and cosponsored by 44 professional societies. More than 20 countries were represented. Evidence Literature review, expert opinion, and input from an Internet bulletin board were all considered in developing recommendations. The strength of evidence of the scientific data was considered of paramount importance. Consensus process Bethesda 2001 was a year-long iterative review process. An Internet bulletin board was used for discussion of issues and drafts of recommendations. More than 1000 comments were posted to the bulletin board over the course of 6 months. The Bethesda Workshop, held April 30-May 2, 2001, was open to the public. Postworkshop recommendations were…

Integrity signals

Registry

Crossref · 10.1001/jama.287.16.2114

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The pathology laboratory used the 2001 Bethesda system for reporting results of cervical cytology and followed standard quality control procedures per the National Accreditation Board for Testing and Calibration Laboratories.
“The pathology laboratory used the 2001 Bethesda system for reporting results of cervical cytology and followed standard quality control procedures per the National Accreditation Board for Testing and Calibration Laboratories [18].”
From A community‐based, cross‐sectional study of hr<scp>HPV DNA</scp> self‐sampling‐based cervical cancer screening in rural Karnataka, India (2019) · cites this paper as [18]

NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN
Loria, G. R., Ierman, R. O. B., Eardsley, L. E. B., & Hang, H. J. C. (1998) · Cited by 1,887 · see citing works
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
Hausen, H. Z. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.690 · Cited by 1,297 · see citing works
2001 Consensus Guidelines for the Management of Women With Cervical Cytological Abnormalities
Wright, T. C. (2002) · JAMA · doi:10.1001/jama.287.16.2120 · Cited by 1,197 · see citing works
Comparison of Three Management Strategies for Patients With Atypical Squamous Cells of Undetermined Significance: Baseline Results From a Randomized Trial
Solomon, D., SCHIFFMAN, M. H., & Tarone, R. E. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.293 · Cited by 958 · see citing works
Self-citation
The 1988 Bethesda system for reporting cervical/vaginal cytologic diagnoses: Developed and approved at the national cancer institute workshop in Bethesda, MD, December 12–13, 1988
Soloman, D. (1989) · Diagnostic Cytopathology · doi:10.1002/dc.2840050318 · Cited by 290 · see citing works
Cervical biopsy-cytology correlation. A College of American Pathologists Q-Probes study of 22 439 correlations in 348 laboratories.
Jones, B. A., & Novis, D. A. (1996) · PubMed · Cited by 181 · see citing works
Qualification of ASCUS
Sherman, M. E., Solomon, D., SCHIFFMAN, M. H., & for the ALTS Group (2001) · American Journal of Clinical Pathology · doi:10.1309/jm3v-u4hp-w8hj-68xv · Cited by 173 · see citing works
Self-citation
Atypical Epithelial Cells and Specimen Adequacy
Davey, D. D., Woodhouse, S. L., Styer, P. E., Stastny, J. F., & Mody, D. R. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0203-aecasa · Cited by 134 · see citing works
The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses.
Hudson, E. A., Dv, C., & Brown, C. L. (1990) · PubMed · Cited by 130 · see citing works
Rapid Communication—The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses—Report of the 1991 Bethesda Workshop
Broder, S. E. (1992) · JAMA · doi:10.1001/jama.1992.03480140014005 · Cited by 127 · see citing works
The bethesda system for reporting cervical/vaginal cytologic diagnoses: Report of the 1991 bethesda workshop
Luff, R. D. (1992) · Human Pathology · doi:10.1016/0046-8177(92)90338-4 · Cited by 113 · see citing works
Significance of endometrial cells in the detection of endometrial carcinoma and its precursors.
Ab, N., Reagan, J. W., Hawliczek, S., & Wentz, W. B. (1974) · PubMed · Cited by 80 · see citing works
Association Between Human Papillomavirus Type and Clonal Status of Cervical Squamous Intraepithelial Lesions
Park, T., Richart, R. M., Sun, X., & Wright, T. C. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.6.355 · Cited by 77 · see citing works
Biopsy findings in five hundred thirty-one patients with atypical glandular cells of uncertain significance as defined by the Bethesda system
Eddy, G. L., Strumpf, K. B., Wojtowycz, M., Piraino, P. S., & Mazur, M. T. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70039-5 · Cited by 73 · see citing works
"ASCUS, rule out HSIL": cytologic features, histologic correlates, and human papillomavirus detection.
Sherman, M. E., Tabbara, S. O., Scott, D. R., Kurman, R. J., Glass, A. G., Manos, M. M., Burk, R. D., Rush, B. B., & SCHIFFMAN, M. H. (1999) · PubMed · Cited by 70 · see citing works
Human Papillomavirus Messenger RNA Expression in Adenocarcinoma In Situ of the Uterine Cervix
Farnsworth, A., Laverty, C. R. A., & Stoler, M. H. (1989) · International Journal of Gynecological Pathology · doi:10.1097/00004347-198912000-00003 · Cited by 70 · see citing works
Comparative cytologic features of adenocarcinoma in situ of the uterine cervix.
Lee, K. R., Manna, E. A., & Jones, M. A. (1991) · PubMed · Cited by 66 · see citing works
Atypical squamous metaplastic cells
Quddus, M. R., Sung, C. J., Steinhoff, M. M., Lauchlan, S. C., Singer, D. B., & Hutchinson, M. L. (2001) · Cancer · doi:10.1002/1097-0142(20010225)93:1 · Cited by 64 · see citing works
Atypical glandular cells of undetermined significance
Soofer, S. B., & Sidawy, M. K. (2000) · Cancer · doi:10.1002/1097-0142(20000825)90:4 · Cited by 57 · see citing works
Significance of endometrial cells in cervicovaginal smears.
Gondos, B., & King, E. B. (1977) · PubMed · Cited by 51 · see citing works
Classification of endometrial cells on cervical cytology.
Yancey, M. K., Magelssen, D. J., Demaurez, A., & Lee, R. B. (1990) · PubMed · Cited by 48 · see citing works
Early endocervical glandular neoplasia. I. Histomorphology and cytomorphology.
Betsill, W. L., & Clark, A. H. (1986) · PubMed · Cited by 42 · see citing works
Significance of “Normal” Endometrial Cells in Cervical Cytology from Asymptomatic Postmenopausal Women Receiving Hormone Replacement Therapy
Montz, F. J. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2000.6106 · Cited by 41 · see citing works
Endocervical adenocarcinoma in situ: An analysis of cellular features
Biscotti, C. V., Gero, M. A., Toddy, S. M., Fischler, D. F., & Easley, K. A. (1997) · Diagnostic Cytopathology · doi:10.1002/(sici)1097-0339(199711)17:5 · Cited by 38 · see citing works
Terminology and specimen adequacy in cervicovaginal cytology. The College of American Pathologists Interlaboratory Comparison Program experience.
Davey, D. D., Nielsen, M. L., Rosenstock, W., & Kline, T. S. (1992) · PubMed · Cited by 35 · see citing works
Correspondence Re: Sherman ME, Tabbara SO, Scott DR, Kurman RJ, Glass AG, Manos MM, et al. “Ascus, Rule Out HSIL”: Cytologic Features, Histologic Correlates, and human Papillomavirus Detection. Mod Pathol 1999;12:335–42.
Koss, L. G. (2000) · Modern Pathology · doi:10.1038/modpathol.3880036 · Cited by 25 · see citing works
Management of women with atypical Papanicolaou tests of undetermined significance by board-certified gynecologists: Discrepancies with published guidelines
Smith‐McCune, K., Mancuso, V., Contant, T., & Jackson, R. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.116725 · Cited by 25 · see citing works
Persistent human papillomavirus infection: Definitions and clinical implications
Einstein, M. H., & Burk, R. D. (2001) · Papillomavirus Report · Cited by 20 · see citing works

Flagged first, then by citations

1 of the 29 references couldn’t be matched to a known paper.

Sorted by citations

Human papillomavirus and cervical cancer
SCHIFFMAN, M. H., Castle, P. E., Jerónimo, J., Rodríguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 3,046 · see citing works
Human papillomavirus and cervical cancer
Burd, E. M. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.1-17.2003 · Cited by 2,420 · see citing works
Sexually transmitted diseases treatment guidelines
Burstein, G. R., & Workowski, K. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200308000-00006 · Cited by 2,077 · see citing works
Sexually Transmitted Diseases Treatment Guidelines, 2010
Workowski, K., & BOLAN, G. A. (2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.04.006 · Cited by 2,074 · see citing works
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
Garland, S. M., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Harper, D. M., Leodolter, S., Tang, G. W. K., Ferris, D. G., Steben, M., Bryan, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061760 · Cited by 1,886 · see citing works
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H., Segnan, N., Gilham, C., Giorgi-Rossi, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62218-7 · Cited by 1,810 · see citing works
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
Villa, L. L., Costa, R. L. R., Petta, C. A., de Andrade, R. P., Ault, K. A., Giuliano, A. R., Wheeler, C. M., Koutsky, L. A., Malm, C., Lehtinen, M., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70101-7 · Cited by 1,593 · see citing works
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406 · see citing works
2001 Consensus Guidelines for the Management of Women With Cervical Cytological Abnormalities
Wright, T. C. (2002) · JAMA · doi:10.1001/jama.287.16.2120 · Cited by 1,197 · see citing works
The Pap Test and Bethesda 2014
Nayar, R., & Wilbur, D. C. (2015) · Journal of the American Society of Cytopathology · doi:10.1016/j.jasc.2015.03.003 · Cited by 1,149 · see citing works
Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer
Mayrand, M., Duarte‐Franco, E., Rodrigues, I., Walter, S. D., Hanley, J. A., Ferenczy, A. S., Ratnam, S., Coutlée, F., & Franco, E. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071430 · Cited by 1,106 · see citing works
The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice
Khan, M. J., Castle, P. E., Lorincz, A. T., Wacholder, S., Sherman, M. E., Scott, D. R., Rush, B. B., Glass, A. G., & SCHIFFMAN, M. H. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji187 · Cited by 1,057 · see citing works
ACOG PRACTICE BULLETIN
Gynecologists (2009) · Cited by 1,035 · see citing works
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology
Darragh, T. M., Colgan, T. J., Cox, J. T., Heller, D. S., Henry, M. R., Luff, R. D., McCalmont, T. H., Nayar, R., Palefsky, J. M., Stoler, M. H., et al. (2012) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.lgt200570 · Cited by 1,014 · see citing works
Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis
Machalek, D. A., Poynten, M., Jin, F., Fairley, C. K., Farnsworth, A., Garland, S. M., Hillman, R. J., Petoumenos, K., Roberts, J. M., Tabrizi, S. N., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70080-3 · Cited by 970 · see citing works
Human papillomavirus molecular biology and disease association
Doorbar, J., Egawa, N., Griffin, H. M., Kranjec, C., & Murakami, I. (2015) · Reviews in Medical Virology · doi:10.1002/rmv.1822 · Cited by 956 · see citing works
2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Massad, L. S., Einstein, M. H., Huh, W. K., Katki, H. A., Kinney, W., Schiffman, M., Solomon, D., Wentzensen, N., & Lawson, H. W. (2013) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3182883a34 · Cited by 927 · see citing works
Self-citation
American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer
Saslow, D., Runowicz, C. D., Solomon, D., Moscicki, A.-B., Smith, R. A., Eyre, H. J., & Cohen, C. J. (2002) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.6.342 · Cited by 913 · see citing works
Self-citation
Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of America
Aberg, J. A., Kaplan, J. E., Libman, H., Emmanuel, P. J., Anderson, J., Stone, V. E., Oleske, J. M., Currier, J. S., & Gallant, J. E. (2009) · Clinical Infectious Diseases · doi:10.1086/605292 · Cited by 831 · see citing works
2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests
Wright, T. C., Massad, L. S., Dunton, C. J., Spitzer, M., Wilkinson, E. J., & Solomon, D. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.07.047 · Cited by 829 · see citing works
Self-citation
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
Villa, L. L., Costa, R. L. R., Petta, C. A., de Andrade, R. P., Paavonen, J. A., Iversen, O. L. E. E., Olsson, S., Høye, J., Steinwall, M., Riis-Johannessen, G., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603469 · Cited by 801 · see citing works
2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Massad, L. S., Einstein, M. H., Huh, W. K., Katki, H. A., Kinney, W., Schiffman, M., Solomon, D., Wentzensen, N., & Lawson, H. W. (2013) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e318287d329 · Cited by 740 · see citing works
Self-citation
Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis
Arbyn, M., Verdoodt, F., Snijders, P. J. F., Verhoef, V. M. J., Suonio, E., Dillner, L., Minozzi, S., Bellisario, C., Banzi, R., Zhao, F.-H., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70570-9 · Cited by 674 · see citing works
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors
Arbyn, M., Xu, L., Simoens, C., & Martin-Hirsch, P. P. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009069.pub3 · Cited by 621 · see citing works
Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test
Wright, T. C., Stoler, M. H., Behrens, C. M., Sharma, A., Zhang, G., & Wright, T. L. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.11.076 · Cited by 601 · see citing works
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice
Katki, H. A., Kinney, W., Fetterman, B. J., Lorey, T. S., Poitras, N. E., Cheung, L. C., Demuth, F., SCHIFFMAN, M. H., Wacholder, S., & Castle, P. E. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70145-0 · Cited by 571 · see citing works
The Lower Anogenital Squamous Terminology Standardization Project for HPV-associated Lesions
Darragh, T. M., Colgan, T. J., Cox, J. T., Heller, D. S., Henry, M. R., Luff, R. D., McCalmont, T. H., Nayar, R., Palefsky, J. M., Stoler, M. H., et al. (2012) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31826916c7 · Cited by 568 · see citing works
Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance
(2003) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(03)00418-6 · Cited by 560 · see citing works
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study
Castle, P. E., Stoler, M. H., Wright, T. C., Sharma, A., Wright, T. L., & Behrens, C. M. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70188-7 · Cited by 526 · see citing works
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial
Rijkaart, D., Berkhof, J. H., Rozendaal, L., van Kemenade, F. J., Bulkmans, N. W. J., Heideman, D. A. M., Kenter, G. G., Cuzick, J. M., Snijders, P. J. F., & Meijer, C. J. L. M. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70296-0 · Cited by 518 · see citing works
Primary Care Guidelines for the Management of Persons Infected With HIV: 2013 Update by the HIV Medicine Association of the Infectious Diseases Society of America
Aberg, J. A., Gallant, J. E., Ghanem, K. G., Emmanuel, P. J., Zingman, B. S., & Horberg, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit665 · Cited by 497 · see citing works
Cytology versus HPV testing for cervical cancer screening in the general population
Koliopoulos, G., Nyaga, V. N., Santesso, N., Bryant, A., Martin-Hirsch, P. P., Mustafa, R. A., Schünemann, H., Paraskevaidis, E., & Arbyn, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008587.pub2 · Cited by 494 · see citing works
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions
Darragh, T. M., Colgan, T. J., Cox, J. T., Heller, D. S., Henry, M. R., Luff, R. D., McCalmont, T. H., Nayar, R., Palefsky, J. M., Stoler, M. H., et al. (2012) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e31825c31dd · Cited by 493 · see citing works
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial
Muñóz, N., Manalastas, R., Pitisuttithum, P., Tresukosol, D., Monsonégo, J., Ault, K. A., Clavel, C., Luna, J., Myers, E. R., Hood, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60691-7 · Cited by 478 · see citing works
Baseline Cytology, Human Papillomavirus Testing, and Risk for Cervical Neoplasia: A 10-Year Cohort Analysis
Sherman, M. E., Lorincz, A. T., Scott, D. R., Wacholder, S., Castle, P. E., Glass, A. G., Mielzynska, I., Rush, B. B., & SCHIFFMAN, M. H. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.1.46 · Cited by 427 · see citing works
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial
The FUTURE I/II Study Group (2010) · BMJ · doi:10.1136/bmj.c3493 · Cited by 414 · see citing works
Cervical Cancer in Women With Comprehensive Health Care Access: Attributable Factors in the Screening Process
Leyden, W. A., Manos, M. M., Geiger, A. M., Weinmann, S. A., Mouchawar, J., Bischoff, K. J., Yood, M. U., Gilbert, J., & Taplin, S. H. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji115 · Cited by 390 · see citing works
Virologic Versus Cytologic Triage of Women With Equivocal Pap Smears: A Meta-analysis of the Accuracy To Detect High-Grade Intraepithelial Neoplasia
Arbyn, M., Buntinx, F., Ranst, M. A. V., Paraskevaidis, E. A., Martin‐Hirsch, P. L., & Dillner, J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh037 · Cited by 357 · see citing works
Diseases associated with human papillomavirus infection
Cubie, H. (2013) · Virology · doi:10.1016/j.virol.2013.06.007 · Cited by 354 · see citing works
2006 Consensus Guidelines for the Management of Women With Abnormal Cervical Screening Tests
Wright, T. C., Massad, L. S., Dunton, C. J., Spitzer, M., Wilkinson, E. J., & Solomon, D. (2007) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e3181585870 · Cited by 353 · see citing works
Self-citation
End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age
Castellsagué, X., Muñóz, N., Pitisuttithum, P., Ferris, D. G., Monsonégo, J., Ault, K. A., Luna, J., Myers, E. R., Mallary, S., Bautista, O. M., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.185 · Cited by 350 · see citing works
Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy
Cox, J. T., SCHIFFMAN, M. H., & Solomon, D. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.461 · Cited by 350 · see citing works
Self-citation
The Pap test and Bethesda 2014
Nayar, R., & Wilbur, D. C. (2015) · Cancer Cytopathology · doi:10.1002/cncy.21521 · Cited by 340 · see citing works
Potential Health and Economic Impact of Adding a Human Papillomavirus Vaccine to Screening Programs
Kulasingam, S. (2003) · JAMA · doi:10.1001/jama.290.6.781 · Cited by 334 · see citing works
A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions
Kjær, S. K., Sigurðsson, K., Iversen, O., Hernández‐Ávila, M., Wheeler, C. M., Pérez, G., Brown, D. R., Koutsky, L. A., Tay, E. H., Garcia, P. J., et al. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0031 · Cited by 333 · see citing works
High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology
Stoler, M. H., Wright, T. C., Sharma, A., Apple, R. J., Gutekunst, K. A., & Wright, T. L. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcpz5jy6fcvnmot · Cited by 327 · see citing works
Human Papillomavirus Infection and the Multistage Carcinogenesis of Cervical Cancer
Schiffman, M., & Wentzensen, N. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1406 · Cited by 326 · see citing works
Cervical Cancer: Prevention and Early Detection
Kessler, T. A. (2017) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2017.02.005 · Cited by 283 · see citing works
Cervical Cancer Prevention—Cervical Screening: Science in Evolution
Safaeian, M., Solomon, D., & Castle, P. E. (2007) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2007.09.004 · Cited by 267 · see citing works
Self-citation
Utility of methylation markers in cervical cancer early detection: Appraisal of the state-of-the-science
Wentzensen, N., Sherman, M. E., SCHIFFMAN, M. H., & WANG, S. S. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.10.012 · Cited by 264 · see citing works
2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities
Wright, T. C., Cox, J. T., Massad, L. S., Twiggs, L. B., & Wilkinson, E. J. (2002) · Journal of Lower Genital Tract Disease · doi:10.1097/00128360-200204000-00012 · Cited by 256 · see citing works
Burden of cervical cancer and role of screening in India
Bobdey, S., Sathwara, J., Jain, A., & Balasubramaniam, G. (2016) · Indian Journal of Medical and Paediatric Oncology · doi:10.4103/0971-5851.195751 · Cited by 254 · see citing works
Findings to Date From the ASCUS-LSIL Triage Study (ALTS)
SCHIFFMAN, M. H., & Solomon, D. (2003) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2003-127-946-ftdfta · Cited by 249 · see citing works
Self-citation
Biomarkers in Cervical Cancer Screening
Wentzensen, N., & Doeberitz, M. V. K. (2007) · Disease Markers · doi:10.1155/2007/678793 · Cited by 242 · see citing works
Higher Incidence of Abnormal Pap Smears in Women With Inflammatory Bowel Disease
Kane, S. V., Khatibi, B., & Reddy, D. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01582.x · Cited by 241 · see citing works
Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort
Peto, J., Gilham, C., Deacon, J., Taylor, C., Evans, C., Wh, B., Haywood, M. E. K., Elanko, N., Coleman, D. V., Yule, R., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602049 · Cited by 236 · see citing works
The Pap Test and Bethesda 2014
Nayar, R., & Wilbur, D. C. (2015) · Acta Cytologica · doi:10.1159/000381842 · Cited by 236 · see citing works
CIN2 Is a Much Less Reproducible and Less Valid Diagnosis than CIN3
Carreon, J. D., Sherman, M. E., Guillén, D., Solomon, D., Herrero, R., Jerónimo, J., Wacholder, S., Rodríguez, A. C., Morales, J., Hutchinson, M. L., et al. (2007) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31805152ab · Cited by 234 · see citing works
Self-citation
p16/ki‐67 dual‐stain cytology in the triage of ASCUS and LSIL Papanicolaou cytology
Schmidt, D., Bergeron, C., Denton, K. J., Ridder, R., & for the European CINtec Cytology Study Group (2011) · Cancer Cytopathology · doi:10.1002/cncy.20140 · Cited by 231 · see citing works
Multiple Biopsies and Detection of Cervical Cancer Precursors at Colposcopy
Wentzensen, N., Walker, J. L., Gold, M. A., Smith, K., Zuna, R. E., Mathews, C. A., Dunn, S. T., Zhang, R., Moxley, K. M., Bishop, E. A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.9948 · Cited by 230 · see citing works
Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study
Ikenberg, H., Bergeron, C., Schmidt, D., Griesser, H., Quitllet, F. A., Angeloni, C., Bogers, J., Dachez, R., Denton, K. J., Hariri, J., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt235 · Cited by 230 · see citing works
Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology
Petry, K. U., Schmidt, D., Scherbring, S., Luyten, A., Reinecke‐Lüthge, A., Bergeron, C., Kommoss, F., Löning, T., Ordï, J., Regauer, S., et al. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.02.033 · Cited by 228 · see citing works
Fourier transform infrared (FTIR) spectral mapping of the cervical transformation zone, and dysplastic squamous epithelium
Wood, B. R., Chiriboga, L. A., Yee, H. T., Quinn, M. A., McNaughton, D., & Diem, M. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.12.028 · Cited by 225 · see citing works
Evaluation of HPV-16 and HPV-18 Genotyping for the Triage of Women With High-Risk HPV+ Cytology-Negative Results
Wright, T. C., Stoler, M. H., Sharma, A., Zhang, G., Behrens, C. M., & Wright, T. L. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcptus5exas6dkz · Cited by 225 · see citing works
Impact of HPV infection in adolescent populations
Moscicki, A. (2005) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2005.09.011 · Cited by 223 · see citing works
Age-Related Prevalence of Anal Cancer Precursors in Homosexual Men: The EXPLORE Study
Chin-Hong, P. V., Vittinghoff, E., Cranston, R., Browne, L., Buchbinder, S., Colfax, G. N., Costa, M. D., Darragh, T. M., Benet, D. J., Judson, F. N., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji163 · Cited by 222 · see citing works
Bethesda 2001 Implementation and Reporting Rates: 2003 Practices of Participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology
Davey, D. D., Neal, M. H., Wilbur, D. C., Colgan, T. J., Styer, P. E., & Mody, D. R. (2004) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2004-128-1224-biarrp · Cited by 222 · see citing works
Human papillomavirus vaccination and cervical cancer risk
Rahangdale, L., Mungo, C., O’Connor, S., Chibwesha, C. J., & Brewer, N. T. (2022) · BMJ · doi:10.1136/bmj-2022-070115 · Cited by 217 · see citing works
The association of uterine cervical microbiota with an increased risk for cervical intraepithelial neoplasia in Korea
Oh, H. Y., Kim, B.-S., Seo, S., Kong, J.-S., Lee, J. K., Park, S.-Y., Hong, K., Kim, H. K., & Kim, M. K. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.02.026 · Cited by 216 · see citing works
Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines
Katki, H. A., SCHIFFMAN, M. H., Castle, P. E., Fetterman, B. J., Poitras, N. E., Lorey, T. S., Cheung, L. C., Raine‐Bennett, T. R., Gage, J. C., & Kinney, W. (2013) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e318285423c · Cited by 213 · see citing works
Cost-Effectiveness of Human Papillomavirus DNA Testing for Cervical Cancer Screening in Women Aged 30 Years or More
Goldie, S. J., Kim, J. J., & Wright, T. C. (2004) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000120143.50098.c7 · Cited by 207 · see citing works
TSLC1 Gene Silencing in Cervical Cancer Cell Lines and Cervical Neoplasia
Steenbergen, R. D. M., Kramer, D., Braakhuis, B. J. M., Stern, P. L., Verheijen, R. H. M., Meijer, C. J. L. M., & Snijders, P. J. F. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh031 · Cited by 204 · see citing works
The 2001 Bethesda System terminology.
Apgar, B. S., Zoschnick, L., & Wright, T. C. (2003) · PubMed · Cited by 203 · see citing works
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine
Joura, E. A., Kjær, S. K., Wheeler, C. M., Sigurðsson, K., Iversen, O., Hernández‐Ávila, M., Pérez, G., Brown, D. R., Koutsky, L. A., Tay, E. H., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.073 · Cited by 198 · see citing works
Early Impact of Human Papillomavirus Vaccination on Cervical Neoplasia--Nationwide Follow-up of Young Danish Women
Baldur‐Felskov, B., Dehlendorff, C., Munk, C., & Kjær, S. K. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt460 · Cited by 186 · see citing works
Mortality trends for cervical squamous and adenocarcinoma in the United States
Sherman, M. E., WANG, S. S., Carreon, J. D., & Devesa, S. S. (2005) · Cancer · doi:10.1002/cncr.20877 · Cited by 185 · see citing works
Prophylactic Efficacy of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Women with Virological Evidence of HPV Infection
The FUTURE II Study Group (2007) · The Journal of Infectious Diseases · doi:10.1086/522864 · Cited by 184 · see citing works
Accuracy and Efficiency of Deep-Learning–Based Automation of Dual Stain Cytology in Cervical Cancer Screening
Wentzensen, N., Lahrmann, B., Clarke, M. A., Kinney, W., Tokugawa, D., Poitras, N. E., Locke, A., Bartels, L., Krauthoff, A., Walker, J. L., et al. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa066 · Cited by 180 · see citing works
Human papillomavirus infection and cervical intraepithelial neoplasia progression are associated with increased vaginal microbiome diversity in a Chinese cohort
Chen, Y., Qiu, X., Wang, W., Li, D., Wu, A., Hong, Z., Di, W. J., & Qiu, L. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05324-9 · Cited by 179 · see citing works
Detection of Hypermethylated Genes in Women with and Without Cervical Neoplasia
Feng, Q., Balasubramanian, A., Hawes, S. E., Touré, P. S., Sow, P. S., Dem, A., Dembélé, B., Critchlow, C. W., Xi, L., Lu, H., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji041 · Cited by 176 · see citing works
Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica
Herrero, R., Wacholder, S., Rodríguez, A. C., Solomon, D., González, P., Kreimer, A. R., Porras, C., Schussler, J. E., Jiménez, S., Sherman, M. E., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0131 · Cited by 176 · see citing works
Self-citation
Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program
Wentzensen, N., Clarke, M. A., Bremer, R. C., Poitras, N. E., Tokugawa, D., Goldhoff, P., Castle, P. E., SCHIFFMAN, M. H., Kingery, J. D., Grewal, K. K., et al. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.0306 · Cited by 174 · see citing works
Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: Data from the ATHENA trial
Monsonégo, J., Cox, J. T., Behrens, C. M., Sandri, M. T., Franco, E. L., Yap, P., & Huh, W. K. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.01.551 · Cited by 172 · see citing works
The role of cytology (Pap tests) and human papillomavirus testing in anal cancer screening
Salit, I. E., Lytwyn, A., Raboud, J., Sano, M., Chong, S., Diong, C. C., Chapman, W. B., Mahony, J. B., & Tinmouth, J. (2010) · AIDS · doi:10.1097/qad.0b013e328339e592 · Cited by 170 · see citing works
Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial
Qiao, Y., Wu, T., Li, R., Hu, Y., Wei, L., Li, C., Chen, W., Huang, S., Zhao, F., Li, M., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz074 · Cited by 170 · see citing works
Genomic Amplification of the Human Telomerase Gene (TERC) in Pap Smears Predicts the Development of Cervical Cancer
Heselmeyer‐Haddad, K., Sommerfeld, K., White, N. M. A., Chaudhri, N., Morrison, L. E., Palanisamy, N., Wang, Z. Y., Auer, G., Steinberg, W., & Ried, T. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62341-3 · Cited by 169 · see citing works
Pooled Analysis of a Self-Sampling HPV DNA Test as a Cervical Cancer Primary Screening Method
Zhao, F., Lewkowitz, A. K., Chen, F., Lin, M., Hu, S., Zhang, X., Pan, Q., Ma, J.-F., Niyazi, M., Li, C.-Q., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr532 · Cited by 169 · see citing works
European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1
Jordan, J. A., Arbyn, M., Martin‐Hirsch, P. L., Schenck, U., Jj, B., Silva, D. D., Anttila, A., Nieminen, P., & Prendiville, W. J. (2008) · Cytopathology · doi:10.1111/j.1365-2303.2008.00623.x · Cited by 167 · see citing works
Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands
Bulk, S., Berkhof, J. H., Bulkmans, N. W. J., Zielinski, G. D., Rozendaal, L., van Kemenade, F. J., Snijders, P. J. F., & Meijer, C. J. L. M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602915 · Cited by 164 · see citing works
Revised Terminology for Cervical Histopathology and Its Implications for Management of High-Grade Squamous Intraepithelial Lesions of the Cervix
Waxman, A. G., Chelmow, D. P., Darragh, T. M., Lawson, H. W., & Moscicki, A. (2012) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31827001d5 · Cited by 163 · see citing works
Clinical Significance of Atypical Glandular Cells on Cervical Cytology
Schnatz, P. F., Guile, M. W., O’Sullivan, D. M., & Sorosky, J. I. (2006) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000202401.29145.68 · Cited by 162 · see citing works
Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China
Zhao, F.-H., Lin, M. J., Chen, F., Hu, S.-Y., Zhang, R., Belinson, J. L., Sellors, J. W., Franceschi, S., Qiao, Y.-L., & Castle, P. E. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70256-4 · Cited by 158 · see citing works
Adults' Knowledge and Behaviors Related to Human Papillomavirus Infection
Holcomb, B., Bailey, J. M., Crawford, K., & Ruffin, M. T. (2004) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.17.1.26 · Cited by 155 · see citing works
The Bethesda System for Reporting Cervical Cytology
Nayar, R., Wilbur, D. C., & Solomon, D. (2008) · Elsevier eBooks · doi:10.1016/b978-141604208-2.10006-5 · Cited by 155 · see citing works
Self-citation
A population‐based study of human papillomavirus genotype prevalence in the United States: Baseline measures prior to mass human papillomavirus vaccination
Wheeler, C. M., Hunt, W. C., Cuzick, J. M., Langsfeld, E. S., Pearse, A., Montoya, G. D., Robertson, M., Shearman, C. A., & Castle, P. E. (2012) · International Journal of Cancer · doi:10.1002/ijc.27608 · Cited by 149 · see citing works
Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: Results from a large academic womens hospital laboratory employing sensitive screening methods
Zhao, C., Florea, A. V., Oniśko, A., & Austin, R. M. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.05.019 · Cited by 149 · see citing works
Evaluation and Management of Anal Intraepithelial Neoplasia in HIV-Negative and HIV-Positive Men Who Have Sex with Men
Park, I. U., & Palefsky, J. M. (2010) · Current Infectious Disease Reports · doi:10.1007/s11908-010-0090-7 · Cited by 149 · see citing works
Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2–3
Alonso, I., Torné, A., Puig‐Tintoré, L. M., Esteve, R., Quintó, L., Campo, E., Pahisa, J., & Ordï, J. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.04.016 · Cited by 149 · see citing works
Multiple Human Papillomavirus Infections with High Viral Loads Are Associated with Cervical Lesions but Do Not Differentiate Grades of Cervical Abnormalities
Schmitt, M., Depuydt, C., Benoy, I. H., Bogers, J., Antoine, J., Arbyn, M., & Pawlita, M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00087-13 · Cited by 148 · see citing works
Susceptibility to cervical cancer: An overview
de Freitas, A. C., Gurgel, A. P. A. D., Chagas, B. S., Coimbra, E. C., & do Amaral, C. M. M. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.03.047 · Cited by 148 · see citing works

The Bethedsa System 2001 Workshop Report
Hong, E.-K., Nam, J., & Park, M.-H. (2001) · The Korean Journal of Cytopathology · Cited by 3 · see citing works
Cervical Cytology Classification and the Bethesda System
Davey, D. D. (2003) · The Cancer Journal · doi:10.1097/00130404-200309000-00002 · Cited by 34 · see citing works
The Bethesda system for reporting cervical/vaginal cytologic diagnoses: Report of the 1991 Bethesda workshop
(1992) · Diagnostic Cytopathology · doi:10.1002/dc.2840080326 · Cited by 8 · see citing works
The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnosis—Report of the 1991 Bethesda Workshop
Broder, S. E. (1992) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199208000-00019
The Bethesda System for reporting cervical/vaginal cytologic diagnoses: revised after the second National Cancer Institute Workshop, April 29-30, 1991.
(1993) · PubMed · Cited by 30 · see citing works

Authors: Solomon, D.
Affiliations: National Institutes of Health (US)
Corresponding author: Solomon, Diane
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2002-04-24
Volume: 287
Issue: 16
Pages: 2114
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.287.16.2114
OpenAlex: W2133765716
Cited by: 3,104
References: 29
Citations by year: 2026: 45 · 2025: 57 · 2024: 65 · 2023: 71 · 2022: 92 · 2021: 95 · 2020: 109 · 2019: 121 · 2018: 139 · 2017: 137 · 2016: 161 · 2015: 189 · 2014: 177 · 2013: 217 · 2012: 203
FWCI: 92.24
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
Keywords: Bethesda system, cervical cytology, cervical cancer screening, cervical neoplasia, consensus development, international cooperation
MeSH terms: Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Female, Humans, Laboratories, Terminology as Topic, Quality Control, Vaginal Smears

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks